PKN1 AS NOVEL THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER

$571,246FY2016Department of the ArmyDOD

The Cleveland Clinic Foundation

Investigators

View source on USAspending →

PKN1 AS NOVEL THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER · GrantIndex